Status:
COMPLETED
Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Cancer Institute (NCI)
Children's Hospital Los Angeles
Conditions:
Childhood Cancers
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators have developed a parent social-cognitive processing intervention (P-SCIP) to help decrease distress among parent caregivers of children undergoing hematopoietic stem cell transplant ...
Eligibility Criteria
Inclusion
- biological or foster parent of children under 19 years of age who are scheduled for HSCT within the next month
- participant is the primary caregiver
- participant must have phone service
- caregiver speaks, reads, and writes English or Spanish (Spanish is for Childrens Hospital Los Angeles and Columbia University only)
Exclusion
- pediatric patient has a diagnosis of medulloblastoma or other cancer of the brain
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT00939380
Start Date
May 1 2010
End Date
May 1 2015
Last Update
March 10 2016
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Hospital Los Angeles
Los Angeles, California, United States, 90027
2
Emory University/Childrens Healthcare of Atlanta
Atlanta, Georgia, United States, 30322
3
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States, 080903
4
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10021